Circulating tumor cells with the invasive phenotype predict progression free survival and overall survival in preoperative patients diagnosed with advanced epithelial ovarian cancer.

被引：0
|
作者：
Chen, Wen-Tien [1 ]
Zhao, Qiang [1 ]
Dong, Huan [1 ]
Yang, Jie [2 ]
Zhang, Qiao [2 ]
Fan, Tina [2 ]
Golightly, Marc G. [2 ]
Dessio, Whitney C. [2 ]
Madajewicz, Stefan [2 ]
Henretta, Melissa [2 ]
Pearl, Michael L. [2 ]
机构：
[1] Vitatex Inc, Stony Brook, NY USA
[2] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-LB-73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB73
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Circulating tumor cells predict survival in patients with metastatic prostate cancer
    Moreno, JG
    Miller, MC
    Gross, S
    Allard, WJ
    Gomella, LG
    Terstappen, LWMM
    UROLOGY, 2005, 65 (04) : 713 - 718
  • [22] Nomogram prediction for overall survival of patients diagnosed with cervical cancer.
    Jagadeesan, S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S696 - S697
  • [23] Nomogram prediction for overall survival of patients diagnosed with cervical cancer.
    Grimm, Christoph
    Reinthaller, Alexander
    Hofstetter, Gerda
    Concin, Nicole
    Marth, Christian
    Polterauer, Stephan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Circulating free DNA and circulating tumor cells as new serum biomarkers in advanced ovarian cancer.
    Garcia, Jeronimo Martinez
    Soto, Asuncion
    Sanchez-Henarejos, Pilar
    Boix, Ana Puertes
    Rodriguez, Edith
    Maran, Marta Guirao
    Jimenez-Lucas, MDolores
    Cuellar, Miler
    Cano, Alicia
    Romero, Jose Luis Alonso
    Merino, Guadalupe Ruiz
    Collados, David
    Marin, Miguel
    Ros, Silver
    Hernandez, Maria Del Rosario Garcia
    Salgado, Rosario
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] EFFECT OF SURGICAL PARADIGM CHANGE ON OVERALL SURVIVAL IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER
    Norppa, N.
    Saarelainen, S.
    Staff, S.
    Auranen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A199 - A199
  • [26] Validity and efficiency of progression-free survival (PFS)-2 as a surrogate endpoint for overall survival (OS) in advanced cancer.
    Woodford, Rachel
    Zhou, Deborah
    Kok, Peey-Sei
    Lord, Sally
    Friedlander, Michael
    Marschner, Ian
    Simes, John
    Lee, Chee Khoon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer
    Shimokawa, M.
    Ohki, M.
    Kaku, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (04) : 370 - 375
  • [28] CORRELATION OF PROGRESSION-FREE AND POST-PROGRESSION SURVIVAL WITH OVERALL SURVIVAL IN PHASE III TRIALS OF FIRST-LINE CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Shimokawa, M.
    Ohki, M.
    Kaku, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 393 - 393
  • [29] Immune biomarkers are predictive of overall survival in advanced epithelial ovarian cancer
    Adams, Sarah F.
    Levine, Douglas A.
    Cadungog, Mark
    Zhang, Lin
    Hammond, Rachel
    Barakat, Richard
    Boyd, Jeff
    Gimotty, Phyllis
    Coukos, George
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S19 - S20
  • [30] Progesteron receptor status as a predictor of progression-free survival and overall survival in patients with early breast cancer.
    Latiano, T.
    D'Addetta, C.
    Murgo, R.
    Piano, A.
    Morritti, M.
    Valori, V.
    Lombardi, L.
    Parrella, P.
    Copetti, M.
    Maiello, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345